Markus Enzelberger works as a Partner at Versant Ventures. The firm's known portfolio counts 10 companies.
Is Markus Enzelberger a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- HardwareHealthcare
Contacts
Affiliated funds' portfolios
Partner at Versant Ventures, whose known portfolio counts 10 companies
- Dualitas Therapeutics
- Light Horse Therapeutics
- 858 Therapeutics
- AllRock Bio
- Antag Therapeutics
- Granite Bio
- Helicore Biopharma
- Dayra Therapeutics
- Gate Bioscience
- Pep2Tango Therapeutics
Investor Profile
The listing covers sectors Hardware and Healthcare, and focus areas Biotech, Drug Discovery, Genetics and Genomics. Startups operating in these areas may find Markus Enzelberger relevant.
Versant Ventures appears in Seed, Series A and Series B rounds across its known deals.
What the affiliated firm has backed is the closest available signal on whether Markus Enzelberger is worth approaching.
Colleagues at Versant Ventures
Showing 20 of 22
Markus Warmuth
Venture Partner
Cambridge, United States
Kirk Nielsen
Managing Director
Minneapolis, United States
Robin Praeger
Managing Director/Advisor
San Francisco, United States
Carlo Rizzuto
Managing Director
New York, United States
Joel Drewry
Principal
Toronto, Canada
Clare Ozawa
Managing Director
San Diego, United States
Jerel Davis
Managing Director
Vancouver, Canada
Beckie Robertson
Founder and General Partner
Palo Alto, United States
Rami Hannoush
Investor
San Francisco, United States
Charles Warden
Managing Director
Burlingame, United States
Don Milder
Managing Partner
Laguna Beach, United States
Ross Jaffe
Managing Director
Los Angeles, United States
Sam Colella
VC
Los Altos, United States
Bill Link
Investor
Irvine, United States
Nikita Sharma
Principal
Basel, Switzerland
Tom Woiwode
Managing Director
San Francisco, United States
Alexander Mayweg
Managing Director
Basel, Switzerland
Guido Magni
Partner
Basel, Switzerland
Peter Emtage
Venture Partner
San Francisco, United States
Max E.
Chief Executive Officer
San Francisco, United States
Frequently asked questions
Who is Markus Enzelberger?
Markus Enzelberger is a venture capital investor based in Munich, Bavaria, Germany, listed as Partner at Versant Ventures. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to Markus Enzelberger personally.
What does Markus Enzelberger invest in?
Listed sectors include Hardware and Healthcare; listed focus areas include Biotech, Drug Discovery, Genetics and Genomics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Markus Enzelberger invest at?
Versant Ventures appears in Seed, Series A and Series B rounds across its known deals, and Markus Enzelberger is listed there as Partner. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Markus Enzelberger listed at?
Markus Enzelberger is listed as Partner at Versant Ventures. 22 other people in the database share a firm with Markus Enzelberger.
How do I contact Markus Enzelberger?
An email address, a phone number and a LinkedIn page are on file for Markus Enzelberger. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal